Literature DB >> 16682847

Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism.

M Gola, M Doga, G Mazziotti, S Bonadonna, A Giustina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16682847     DOI： 10.1007/BF03345556

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  14 in total

1.  No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves' disease.

Authors:  Nobuyuki Amino; Yukiko Izumi; Yoh Hidaka; Keiko Takeoka; Yukiko Nakata; Ke-Ita Tatsumi; Atsuo Nagata; Toru Takano
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

Review 2.  Thyroiditis.

Authors:  Elizabeth N Pearce; Alan P Farwell; Lewis E Braverman
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

3.  Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.

Authors:  Y Ueta; H Fukui; H Murakami; Y Yamanouchi; R Yamamoto; A Murao; Y Santou; S Taniguchi; Y Mitani; C Shigemasa
Journal:  Thyroid       Date:  1999-02       Impact factor: 6.568

4.  Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations.

Authors:  R Volpé; R Ehrlich; G Steiner; V V Row
Journal:  Am J Med       Date:  1984-09       Impact factor: 4.965

5.  Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism.

Authors:  Z Kraiem; E Baron; L Kahana; O Sadeh; M Sheinfeld
Journal:  Clin Endocrinol (Oxf)       Date:  1992-02       Impact factor: 3.478

6.  Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.

Authors:  A W Kung; K S Lau; L D Kohn
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy.

Authors:  Mario Rotondi; Gherardo Mazziotti; Francesca Sorvillo; Marco Piscopo; Michele Cioffi; Giovanni Amato; Carlo Carella
Journal:  Eur J Endocrinol       Date:  2004-12       Impact factor: 6.664

8.  Increased need for thyroxine during pregnancy in women with primary hypothyroidism.

Authors:  S J Mandel; P R Larsen; E W Seely; G A Brent
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

9.  Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism.

Authors:  Erik K Alexander; Ellen Marqusee; Jennifer Lawrence; Petr Jarolim; George A Fischer; P Reed Larsen
Journal:  N Engl J Med       Date:  2004-07-15       Impact factor: 91.245

10.  Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.

Authors:  S Costagliola; N G Morgenthaler; R Hoermann; K Badenhoop; J Struck; D Freitag; S Poertl; W Weglöhner; J M Hollidt; B Quadbeck; J E Dumont; P M Schumm-Draeger; A Bergmann; K Mann; G Vassart; K H Usadel
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958
View more
  2 in total

1.  New-Onset Graves' Disease in the Background of Hashimoto's Thyroiditis: Spectrums of the Same Disease With Changing Autoantibodies.

Authors:  Iqra Arshad; Tasneem Zahra; Julia Vargas-Jerez
Journal:  Cureus       Date:  2022-08-23

2.  Occurrence and response to treatment of Graves' disease after COVID vaccination in two male patients.

Authors:  Luigi di Filippo; Laura Castellino; Andrea Giustina
Journal:  Endocrine       Date:  2021-11-02       Impact factor: 3.925
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.